McNicoll Lewis & Vlak on Aastrom Biosciences' (ASTM) Phase II Results; Ixmyelocel-T Autologous Stem Cell Therapy Improves Heart Function

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to McNicoll Lewis & Vlak on Aastrom Biosciences' (ASTM) Phase II Results; Ixmyelocel-T Autologous Stem Cell Therapy Improves Heart Function
AASTROM BIOSCIENCES (NASDAQ: ASTM) Delayed: 2.77 --0 (-0%)
Previous Close $2.77    52 Week High $7.00 
Open $0.94    52 Week Low $2.55 
Day High $2.77    P/E N/A 
Day Low $2.77    EPS $-23.68 
Volume 46,665